Nephrocare Health Services
add_icon

Nephrocare Health Services

710.80
+13.75
(1.97%)
Market Cap
7,132.22 Cr
PE Ratio
82.43
Volume
1,73,558.00
Day High - Low
715.70 - 697.55
52W High-Low
769.75 - 446.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
7,132.22 Cr
EPS
8.48
PE Ratio
82.43
PB Ratio
6.28
Book Value
111.03
EBITDA
251.50
Dividend Yield
0.00 %
Return on Equity
6.88
Debt to Equity
0.20
Analyst Rating and Forecast
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Nephrocare Health Services acquires 100% stake in Dialysis Center Almaty LLP for approx ₹116.35 million. The target entity reported turnover of approx ₹10.93 crore in 2025.
neutral
Nephrocare Health Services' Uzbek subsidiary faces a tax audit order for UZS 18.26 billion. The company attributes the discrepancy to data reconciliation issues and expects no material impact.
neutral
Nephrocare Health Services Limited will hold an investor conference at the Grand Hyatt, Mumbai, on August 18, 2026. The session aims to engage with analysts and institutional investors.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,901.50
#1 31,876.32
57.60
#1 2,864.20
12.11
#1 510
27.24
48.25
1,497.60
15,409.81
82.22
814.20
16.36
182
37.56
57.08
579.65
12,017.75
60.32
1,671.40
24.15
191
25.61
59.73
570.15
9,074.81
52.14
846.00
20.48
163
33.94
46.82
710.80
#5 7,132.22
#9 82.43
#4 1,023.40
#2 32.93
#6 77
#4 35.02
53.13
563.60
1,828.24
18.62
772.77
4.05
106
-19.51
52.18
338.70
1,763.98
49.32
313.60
22.55
31
40.22
65.58
1,517.90
1,302.76
22.34
141.92
27.17
61
-28.57
67.65
524.90
1,025.81
#1 14.34
498.18
#1 237.06
69
#1 45.92
43.94
298.70
950.18
-35.69
1,319.27
12.68
-3
-92.48
49.38

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
32.93 %
Net Income Growth
14.46 %
Cash Flow Change
71.84 %
ROE
-40.12 %
ROCE
-11.39 %
EBITDA Margin (Avg.)
4.64 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
203
223
234
250
263
277
289
Expenses
153
168
180
182
199
215
221
EBITDA
50
55
54
68
64
62
68
Operating Profit %
22 %
23 %
21 %
26 %
23 %
19 %
21 %
Depreciation
18
19
20
23
22
26
25
Interest
5
6
6
45
6
3
2
Profit Before Tax
26
30
29
-1
36
33
41
Tax
6
5
5
9
4
3
9
Net Profit
20
25
24
-10
32
30
32
EPS in ₹
2.47
3.05
2.82
-1.12
3.43
3.03
3.19

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
2026
Total Assets
428
571
666
806
997
1,471
Fixed Assets
192
205
239
356
396
517
Current Assets
178
285
324
390
545
839
Capital Work in Progress
2
43
34
1
6
6
Investments
0
0
0
0
51
178
Other Assets
234
322
393
450
544
771
Total Equity & Liabilities
428
571
666
806
997
1,471
Current Liabilities
94
94
175
243
284
299
Non Current Liabilities
75
81
103
150
129
55
Total Equity
259
396
389
414
584
1,117
Reserve & Surplus
245
387
384
409
579
1,096
Share Capital
4
5
5
2
2
20

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
2026
Net Cash Flow
5
6
-5
47
65
-2
Investing Activities
-62
-130
-76
-52
-125
-392
Operating Activities
32
14
11
72
135
233
Financing Activities
36
121
60
27
54
157

Share Holding

% Holding
Jul 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
79.05 %
63.85 %
63.85 %
63.85 %
FIIs
0.00 %
9.30 %
9.94 %
8.78 %
DIIs
0.00 %
8.10 %
8.65 %
9.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.92 %
5.08 %
5.70 %
Others
20.94 %
12.82 %
12.48 %
12.62 %
No of Share Holders
65
36
43,409
44,091

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2026 512.90 527.50
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2026 529.25 642.10
11 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Aug 2026 678.05 696.15
12 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
12 Aug 2026 635.95 712.30

Announcements

Disclosure Under Regulation 30 Of The SEBI Listing Regulations - Grant Of Esops Under The Nephroplus Employee Stock Option Scheme 2026.4 days ago
Announcement under Regulation 30 (LODR)-Acquisition5 days ago
Disclosure Under Regulation 30 Of SEBI Listing Regulations6 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 17, 2026
Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 13, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 13, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsAug 13, 2026
Announcement under Regulation 30 (LODR)-Updates on AcquisitionAug 12, 2026
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 11, 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On August 11 2026.Aug 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationAug 11, 2026
Financial Results For The Quarter Ended June 30 2026Aug 11, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 10, 2026
Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations 2015Aug 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2026
Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 Inter Alia To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter EJul 24, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 17, 2026
Disclosure Under Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Jul 16, 2026
Notice Of 17Th Annual General Meeting Of The Company To Be Held On Wednesday August 12 2026.Jul 16, 2026
Reg. 34 (1) Annual Report.Jul 16, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Issuance Of Standby Letter Of Credit FacilitiesJul 06, 2026
Issuance Of Corporate Guarantee And Standby Letter Of Credit FacilitiesJun 25, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJun 25, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJun 23, 2026
Disclosure Under Regulation 30 - Approval Of Nephroplus Employee Stock Option Scheme 2026.Jun 22, 2026
Closure of Trading WindowJun 19, 2026
Cancellation Of Scheduled Analyst / Institutional Investor MeetingsJun 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 11, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJun 10, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsJun 04, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 27, 2026
Announcement under Regulation 30 (LODR)-AcquisitionMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 26, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsMay 26, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 20, 2026
Re-Appointment Of Internal AuditorMay 19, 2026
Issuance Of Corporate GuaranteeMay 19, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 19, 2026

Technical Indicators

RSI(14)
Neutral
53.13
ATR(14)
Volatile
25.40
STOCH(9,6)
Neutral
51.19
STOCH RSI(14)
Neutral
75.56
MACD(12,26)
Bullish
0.03
ADX(14)
Weak Trend
20.96
UO(9)
Bearish
42.49
ROC(12)
Uptrend And Accelerating
0.88
WillR(14)
Neutral
-45.00